Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOM001 in Adults With Chronic Insomnia
NCT07920185Phase 2Not yet recruiting
- Start
- Feb 2027
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Insomnia (5 arms). Primary endpoints: Treatment-related adverse events at 3 weeks, Incidence, severity, and relationship of adverse events at 3 weeks and 1 more. Planned start Feb 2027; status: not yet recruiting.
02
Conditions
Insomnia
Beyond the preview
Go deeper on NCT07920185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07920185.